Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

Clinical trial NCT06211335 · RECRUITING

Trial details

NCT number: NCT06211335
Sponsor: University of California, Davis
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Recurrent Head and Neck Squamous Cell Carcinoma Metastatic Head and Neck Squamous Cell Carcinoma Refractory Head and Neck Squamous Cell Carcinoma

Start date: 2023-12-07
Primary completion: 2026-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.